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Abstract
Objectives: The study was aimed to evaluate the oxidative/nitrosative stress status in prostate cancer (CaP) and benign prostatic hyperplasia (BPH).
Design and methods: 312 men from two different populations were included: 163 men from Macedonia (73 CaP patients, 67 BPH patients
and 23 control subjects) and 149 men from Turkey (34 prostate cancer patients, 100 BPH patients and 15 control subjects). We measured
erythrocyte malondialdehyde (MDA) levels, erythrocyte activities of superoxide dismutase (CuZn-SOD), glutathione peroxidase (GPX) and
catalase (CAT); plasma nitrite/nitrate (NO2
−/NO3
−), cGMP and 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels.
Results: A similar pattern of alteration in the oxidative/nitrosative stress-related parameters was found in both, Macedonian and Turkish
studied samples: higher MDA concentrations with lower GPX and CuZn-SOD activities in CaP patients versus controls and BPH groups. The
CAT activity was decreased in the CaP patients versus controls in the Turkish studied sample. Furthermore, CaP patients had increased plasma
NO2
−/NO3
− and cGMP levels versus controls and BPH groups in both studied samples.
Conclusions: This study has confirmed an imbalance in the oxidative stress/antioxidant status and revealed an altered nitrosative status in
prostate cancer patients.
© 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
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Introduction
Prostate cancer continues to be the most frequently diag-
nosed neoplasm, and the second leading cause of cancer-related
mortality in men [1]. The cause of this disease is not well
understood; however, certain factors are commonly linked to its
development. Nonmodifiable risk factors include age, race, and
genetic/family history; diet is a modifiable risk factor [2].
Oxidative stress is an inevitable consequence of aerobic life.
Growing evidence indicates that the cumulative production of
reactive oxygen (ROS) and nitrogen species (RNS) through
either endogenous or exogenous insults plays a major role in the
aging process and age-related diseases such as prostate cancer
[3,4]. Oxygen radicals are associated with different steps of
carcinogenesis, either through structural DNA damage, inter-
action with oncogenes or tumor suppressor genes or immuno-
logical mechanisms [5]. In addition, oxygen radicals may also
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